Loading...
Cash Pay Aesthetics Exposure Will Test Injectable Demand Yet Long Term Potential Remains
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-62.2%7D
1.9%1Y
-62.2%7D
1.9%You can edit this narrative until Feb 3 2:10 PM. Then, changes will post as Updates.